- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05857410
Scheme of Limb Warming Blanket Combined With Dexmedetomidine
May 4, 2023 updated by: Wei Fan, Jincheng General Hospital
Clinical Effect Observation of Lower Limb Warming Blanket Combined With Dexmedetomidine in Preventing Postoperative Delirium and Chills in Elderly Patients Undergoing Spinal Surgery
Objective: To observe the clinical effect of lower limb warming blanket combined with dexmedetomidine (DEX) in preventing postoperative delirium (POD) and chills in elderly patients undergoing spinal surgery.
Methods: A total of 160 elderly patients undergoing posterior spinal surgery under general anesthesia were selected and divided into control group (group N), heating group (group T), DEX group (group D) and heating combined with DEX group (group TD) according to the random number table method, 40 cases in each group.
T group and TD group routine insulation and lower limb heating blanket.
DEX was injected in group D and group TD.
The dosage of anesthetics, the changes of body temperature and heart rate at different time points during operation, and the occurrence of postoperative chills and POD were compared among the groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanxi
-
Jincheng, Shanxi, China, 048006
- Jincheng General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age: between 65-80 years old;
- American Society of Anesthesiologists (ASA) grade II-III;
- Normal body temperature before operation;
- the operation time was 2-4 hours
Exclusion Criteria:
- Preoperative fever or hypothermia (body temperature≥37.5 ℃ or≤35.5℃ on the day of operation);
- Body mass index (BMI) >30 kg/m2;
- The existence of heart, brain, lung, kidney and other important organs and circulatory system, respiratory system, immune system, central nervous system diseases;
- Patients who had taken antipsychotic drugs or β-blockers before surgery would have a greater impact on intraoperative body temperature and other patients who could not effectively cooperate with this study;
- Patients with operation time more than 5 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group (group N)
|
|
|
Active Comparator: heating group (group T)
|
Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.
|
|
Active Comparator: DEX group (group D)
|
Dexmetomidine (H20183219) 0.4μg / (kg·min);
|
|
Experimental: heating combined with DEX group (group TD)
|
Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.
Dexmetomidine (H20183219) 0.4μg / (kg·min);
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative vital signs monitoring
Time Frame: 1 hour
|
nasopharyngeal temperature
|
1 hour
|
|
Intraoperative vital signs monitoring
Time Frame: 2 hour
|
nasopharyngeal temperature
|
2 hour
|
|
Intraoperative vital signs monitoring
Time Frame: 3 hour
|
nasopharyngeal temperature
|
3 hour
|
|
The incidence of postoperative chills
Time Frame: 1 hour
|
chills refer to the Wrench classification criteria as follows : 0: no chills; grade 1: peripheral vascular contraction, vertical hair, but no muscle fibrillation; level 2: only one muscle group had muscle fibrillation; grade 3: muscle fibrillation in multiple groups; level 4: general tremor; ≥ 1 level was judged to have chills.
|
1 hour
|
|
The incidence of POD after operation
Time Frame: 1 day
|
The results of POD in each group were recorded, and the POD was evaluated by CAM-CR scale.
The incidence of POD at 24,48 and 72 h after operation was compared among the groups
|
1 day
|
|
Postoperative extubation time
Time Frame: 1 hour
|
The recovery time from the end of surgery to extubation was recorded.
|
1 hour
|
|
Postoperative incision infection rate
Time Frame: 1 hour
|
The incidence of postoperative incision infection was recorded.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Actual)
December 30, 2022
Study Completion (Actual)
January 25, 2023
Study Registration Dates
First Submitted
April 23, 2023
First Submitted That Met QC Criteria
May 4, 2023
First Posted (Actual)
May 12, 2023
Study Record Updates
Last Update Posted (Actual)
May 12, 2023
Last Update Submitted That Met QC Criteria
May 4, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JinchengGH001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.